No summary has been written for this.
WisdomTree BioRevolution Fund is an exchange-traded fund that seeks to track the performance of the WisdomTree BioRevolution Index before fees and expenses. The fund provides targeted exposure to developed-market companies involved in genetics and biotechnology, with a portfolio designed to reflect businesses benefiting from advances in areas such as human health, biopharmaceuticals, genomics, agricultural innovation, and related life sciences applications. It uses a passive, index-based approach and typically holds a diversified basket of companies that may be reshaping healthcare, research tools, and bioengineering-related industries. WisdomTree BioRevolution Fund is used by market participants seeking concentrated access to the BioRevolution theme through a single listed product. Founded in 2021 and managed by WisdomTree, the fund serves as a thematic equity vehicle within the broader innovation and healthcare investment universe.
The latest articles about WDNA.
No summary yet.
No summary yet.
No summary yet.
No summary yet.
No summary yet.